Display options
Cite
Zhang Z, Li H, Manjanatha MG, et al. Neonatal exposure of 17β-estradiol has no effects on mutagenicity of 7,12-dimethylbenz [a] anthracene in reproductive tissues of adult mice. Genes Environ. 2015;37:16doi: 10.1186/s41021-015-0011-y.
Zhang, Z., Li, H., Manjanatha, M. G., Chen, T., & Mei, N. (2015). Neonatal exposure of 17β-estradiol has no effects on mutagenicity of 7,12-dimethylbenz [a] anthracene in reproductive tissues of adult mice. Genes and environment : the official journal of the Japanese Environmental Mutagen Society, 3716. https://doi.org/10.1186/s41021-015-0011-y
Zhang, Zhuhong, et al. "Neonatal exposure of 17β-estradiol has no effects on mutagenicity of 7,12-dimethylbenz [a] anthracene in reproductive tissues of adult mice." Genes and environment : the official journal of the Japanese Environmental Mutagen Society vol. 37 (2015): 16. doi: https://doi.org/10.1186/s41021-015-0011-y
Zhang Z, Li H, Manjanatha MG, Chen T, Mei N. Neonatal exposure of 17β-estradiol has no effects on mutagenicity of 7,12-dimethylbenz [a] anthracene in reproductive tissues of adult mice. Genes Environ. 2015 Jul 30;37:16. doi: 10.1186/s41021-015-0011-y. eCollection 2015. PMID: 27350812; PMCID: PMC4918036.
Copy Download .nbib Format: NLM
Share it on

Genes Environ. 2015 Jul 30;37:16. doi: 10.1186/s41021-015-0011-y. eCollection 2015.

Neonatal exposure of 17β-estradiol has no effects on mutagenicity of 7,12-dimethylbenz [a] anthracene in reproductive tissues of adult mice.

Genes and environment : the official journal of the Japanese Environmental Mutagen Society

Zhuhong Zhang, Haifang Li, Mugimane G Manjanatha, Tao Chen, Nan Mei

Affiliations

  1. Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079 USA ; Tianjin Medical University General Hospital, Tianjin, 300052 China.
  2. Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079 USA ; Xinjiang Institute for Food and Drug Control, Urumqi, Xinjiang 830004 China.
  3. Division of Genetic and Molecular Toxicology, National Center for Toxicological Research, Jefferson, AR 72079 USA.

PMID: 27350812 PMCID: PMC4918036 DOI: 10.1186/s41021-015-0011-y

Abstract

INTRODUCTION: Biological studies in animals and epidemiological findings in humans clearly demonstrate that estrogens including 17β-estradiol (E2) are weak carcinogens via both genetic and epigenetic mechanisms. Carcinogenesis analyses have indicated that female mice exposed to E2 as neonates develop more mammary and ovarian tumors when compared to adult exposures. In the present study, Big Blue transgenic mice were used to investigate the effects of E2 on mutagenicity of 7,12-dimethylbenz [a] anthracene (DMBA), a genotoxic carcinogen, in mammary gland and ovary following neonatal exposure.

RESULTS: DMBA treatment resulted in significant increases in cII mutant frequencies (MFs) in both mammary glands and ovaries, with A:T → T:A transversion as the predominant type of mutation. However, co-exposure to E2 daily for the first 5 days after birth and to DMBA at 6 months of age did not significantly increase cII MFs compared to DMBA treatment alone. Further, there were also no significant differences in mutational spectra between DMBA exposure alone and E2 + DMBA treatment.

CONCLUSION: These results suggest that early life exposures of mice to estrogens like E2 do not enhance mutagenicity by subsequent exposure to a chemical like DMBA in later life.

Keywords: 17 β-estradiol; Mammary gland; Mutagenicity; Neonatal exposure; Ovary

References

  1. Biol Reprod. 1999 Oct;61(4):851-6 - PubMed
  2. J Environ Pathol Toxicol. 1980 Nov;4(5-6):81-95 - PubMed
  3. J Transl Med. 2014 Apr 08;12:93 - PubMed
  4. Lancet. 1997 Jul 5;350(9070):23-7 - PubMed
  5. Endocr Rev. 2000 Feb;21(1):40-54 - PubMed
  6. Cochrane Database Syst Rev. 2012 Jul 11;(7):CD004143 - PubMed
  7. Environ Health Perspect. 2003 Apr;111(4):389-94 - PubMed
  8. J Natl Cancer Inst. 1975 Jun;54(6):1369-72 - PubMed
  9. Carcinogenesis. 2000 Feb;21(2):265-73 - PubMed
  10. Biol Reprod. 2014 Oct;91(4):100 - PubMed
  11. Nutr Cancer. 2005;53(1):82-90 - PubMed
  12. J Mol Biol. 1987 Apr 5;194(3):391-6 - PubMed
  13. Environ Mol Mutagen. 2005 Jun;45(5):409-18 - PubMed
  14. Adv Clin Exp Med. 2012 Jul-Aug;21(4):535-43 - PubMed
  15. Mutat Res. 2005 May 2;572(1-2):14-26 - PubMed
  16. Mutat Res. 1998 Jun 5;401(1-2):165-78 - PubMed
  17. Steroids. 2015 Jul;99(Pt A):56-60 - PubMed
  18. Carcinogenesis. 1994 Oct;15(10):2281-5 - PubMed
  19. Environ Mol Mutagen. 2000;36(4):283-91 - PubMed
  20. Science. 1999 Aug 20;285(5431):1259-61 - PubMed
  21. FASEB J. 2014 Dec;28(12):5042-54 - PubMed
  22. Steroids. 2013 Jun;78(6):530-7 - PubMed
  23. Carcinogenesis. 2006 Dec;27(12):2555-64 - PubMed
  24. Crit Rev Toxicol. 2014 Sep;44(8):696-724 - PubMed
  25. Biol Reprod. 2009 Mar;80(3):425-31 - PubMed
  26. Birth Defects Res B Dev Reprod Toxicol. 2011 Oct;92(5):421-68 - PubMed
  27. Environ Mol Mutagen. 2005;45(1):70-9 - PubMed
  28. Toxicol Sci. 2010 Sep;117(1):72-80 - PubMed
  29. Cancer Lett. 2004 Nov 25;215(2):151-8 - PubMed
  30. FASEB J. 2013 May;27(5):1874-86 - PubMed
  31. J Steroid Biochem Mol Biol. 2011 Nov;127(3-5):204-15 - PubMed
  32. Natl Toxicol Program Tech Rep Ser. 2008 Jan;(545):1-240 - PubMed
  33. Breast. 2013 Aug;22 Suppl 2:S38-43 - PubMed
  34. Cancer Res. 1988 Jan 15;48(2):425-9 - PubMed
  35. Toxicol Sci. 2004 Sep;81(1):112-20 - PubMed

Publication Types